Loading...
Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes
Randomized clinical trials (RCTs) are no longer the sole source of data to inform guidelines, regulatory, and policy decisions. Real-world data (RWD), collected from registries, electronic health records, insurance claims, pharmacy records, social media, and sensor outputs from devices form real-wor...
Na minha lista:
| Udgivet i: | J Diabetes Sci Technol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6835188/ https://ncbi.nlm.nih.gov/pubmed/30943790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296819839996 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|